Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Christian Kandziora"'
Autor:
Manja Meggendorfer, Guido Kobbe, Detlef Haase, Nicolaus Kröger, Christian Thiede, Christina Ganster, Ulrich Germing, Annika Gutermuth, Piroska Klement, Felicitas Thol, Uwe Platzbecker, Peter Valent, Anne Sophie Kubasch, Wolfgang R. Sperr, Gudrun Göhring, Anna Mies, Johannes Schiller, Thomas Schroeder, Sabrina Klesse, Arnold Ganser, Claudia Haferlach, Brigitte Schlegelberger, Christian Koenecke, Christian Kandziora, Katayoon Shirneshan, Rabia Shahswar, Victoria Panagiota, Konstanze Döhner, Michael Heuser, Jan Krönke, Razif Gabdoulline, Torsten Haferlach
Publikováno v:
American Journal of Hematology. 96
Autor:
Piroska Klement, Walter Fiedler, Razif Gabdoulline, Louisa-Kristin Dallmann, Clara Wienecke, Johannes Schiller, Christian Kandziora, Katrin Teich, Bennet Heida, Maximilian Brandes, Carolin Funke, Martin Wichmann, Basem Othman, Jörg Chromik, Konstantin Büttner, Stefanie Amberg, Maxim Kebenko, Vera Schlipfenbacher, Anne C Wilke, Franziska Modemann, Melanie Janning, Hubert Serve, Carsten Bokemeyer, Ute Deppermann, Anne L. Kranich, Arnold Ganser, Felicitas Thol, Michael Heuser
Publikováno v:
Blood. 138:2369-2369
Introduction Selinexor is an exportin-1 (XPO1) inhibitor which forces the nuclear retention and functional activation of tumor suppressor proteins, inducing apoptosis in cancer cells. Overexpression of XPO-1 is common in many tumors, including acute
Autor:
Lars Bullinger, Richard F. Schlenk, Gudrun Göhring, Lothar Hambach, Konstantin Büttner, Albert Heim, Bennet Heida, Alessandro Liebich, Michael Heuser, Piroska Klement, Iyas Hamwi, Felicitas Thol, Hartmut Döhner, Razif Gabdoulline, Christian Kandziora, Anuhar Chaturvedi, Johannes Schiller, Martin Wichmann, Mira Pankratz, Peter Paschka, Matthias Eder, Arnold Kloos, Sabrina Klesse, Arnold Ganser, Christian Koenecke, Brigitte Schlegelberger, Madita Flintrop, Konstanze Döhner, Jürgen Krauter, Blerina Neziri, Walter Fiedler, Michael B. Stadler, Verena I. Gaidzik
Publikováno v:
Blood
Molecular measurable residual disease (MRD) assessment is not established in approximately 60% of acute myeloid leukemia (AML) patients because of the lack of suitable markers for quantitative real-time polymerase chain reaction. To overcome this lim
Autor:
Manja Meggendorfer, Wolfgang R. Sperr, Guido Kobbe, Detlef Haase, Gudrun Göhring, Claudia Haferlach, Ulrich Germing, Rabia Shahswar, Christian Kandziora, Anne Sophie Kubasch, Annika Gutermuth, Nicolaus Kroeger, Christian Thiede, Victoria Panagiota, Anna Mies, Piroska Klement, Katayoon Shirneshan, Sabrina Klesse, Arnold Ganser, Uwe Platzbecker, Brigitte Schlegelberger, Peter Valent, Felicitas Thol, Thomas Schroeder, Christian Koenecke, Christina Ganster, Johannes Schiller, Michael Heuser, Jan Krönke, Razif Gabdoulline, Torsten Haferlach, Konstanze Döhner
Publikováno v:
Blood. 132:4360-4360
Background: PPM1D is a serine/threonine phosphatase that inactivates p53 tumor suppressor pathway. Recently, PPM1D mutations have been described in clonal hematopoiesis and are more frequently found in therapy-related MDS than in primary MDS (15% vs.